Abundance of Phase 1 and 2 Drug-Metabolizing Enzymes in Alcoholic and Hepatitis C Cirrhotic Livers: A Quantitative Targeted Proteomics Study-Reference-Cited by-同舟云学术

Abundance of Phase 1 and 2 Drug-Metabolizing Enzymes in Alcoholic and Hepatitis C Cirrhotic Livers: A Quantitative Targeted Proteomics Study

Published:2018-04-25 Issue:7 Volume:46 Page:943-952
ISSN:0090-9556
Container-title:Drug Metabolism and Disposition
language:en
Short-container-title:Drug Metab Dispos

Author:

Prasad Bhagwat,Bhatt Deepak Kumar,Johnson Katherine,Chapa Revathi,Chu Xiaoyan,Salphati Laurent,Xiao Guangqing,Lee Caroline,Hop Cornelis E. C. A.,Mathias Anita,Lai Yurong,Liao Mingxiang,Humphreys William G.,Kumer Sean C.,Unadkat Jashvant D.

Publisher

American Society for Pharmacology & Experimental Therapeutics (ASPET)

Subject

Pharmaceutical Science,Pharmacology

Reference47 articles.

1. Protein expression of various hepatic uridine 5′-diphosphate glucuronosyltransferase (UGT) enzymes and their inter-correlations: a meta-analysis

2. Selective effect of liver disease on the activities of specific metabolizing enzymes: Investigation of cytochromes P450 2C19 and 2D6*

3. Impact of Inflammation on Chlorpromazine-Induced Cytotoxicity and Cholestatic Features in HepaRG Cells

4. 3′-azido-3′-deoxythimidine (AZT) is glucuronidated by human UDP-glucuronosyltransferase 2B7 (UGT2B7);Barbier;Drug Metab Dispos,2000

Cited by 75 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Physiologically‐based pharmacokinetic modeling predicts the drug interaction potential of GLS4 in co‐administered with ritonavir;CPT: Pharmacometrics & Systems Pharmacology;2024-06-20

2. Physiologically Based Pharmacokinetic Modeling to Predict the Impact of Liver Cirrhosis on Glucuronidation via UGT1A4 and UGT2B7/2B4—A Case Study with Midazolam;Drug Metabolism and Disposition;2024-04-23

3. Simultaneously Predicting the Pharmacokinetics of CES1-Metabolized Drugs and Their Metabolites Using Physiologically Based Pharmacokinetic Model in Cirrhosis Subjects;Pharmaceutics;2024-02-05

4. Complementarity of two proteomic data analysis tools in the identification of drug-metabolising enzymes and transporters in human liver;Molecular Omics;2024

5. Inhibitory Effects of Tricyclic Antidepressants on Human Liver Microsomal Morphine Glucuronidation: Application of IVIVE to Predict Potential Drug-Drug Interactions in Humans;Current Drug Metabolism;2023-12